Alembic Pharmaceuticals Draws Form 483 Over Five Quality Observations

Alembic Pharmaceuticals, a sterile drug manufacturer in Gujarat, India, drew a Form 483 inspection report from the FDA with five observations following a Jan. 28 – Feb. 6 inspection.
Source: Drug GMP Report